Profile data is unavailable for this security.
About the company
China Medical System Holdings Ltd is an investment holding company principally engaged in the production of medicines, as well as marketing, promotion and sales of drugs. The Company's products include Plendil, Ursofalk, Augentropfen Stulln Mono Eye Drops, Hirudoid, Atopic Piel Series and Vmonalisa, among others. Its major marketed products cover the cardio-cerebrovascular, gastroenterology, ophthalmology, dermatology and medical aesthetic fields. The Company distributes its products within domestic market and to overseas markets.
- Revenue in HKD (TTM)8.89bn
- Net income in HKD1.87bn
- Incorporated2006
- Employees6.10k
- LocationChina Medical System Holdings LtdUnit 2106, 21/F, Island Place Tower, 510, North Point Hong KongHKG
- Phone+86 75 582416868
- Fax+86 75 582416622
- Websitehttps://web.cms.net.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ab&B Bio Tech Co Ltd JS | 366.15m | -253.82m | 20.18bn | 583.00 | -- | 530.23 | -- | 55.12 | -0.6451 | -0.6451 | 0.9306 | 0.0968 | -- | -- | -- | -- | -- | -- | -- | -- | 67.29 | -- | -69.32 | -- | 0.3162 | -9.49 | 0.9646 | -- | 397.65 | -- | 39.09 | -- | -- | -- |
| HUTCHMED (China) Ltd | 4.71bn | 3.65bn | 20.22bn | 1.78k | 5.54 | 2.10 | 5.39 | 4.30 | 4.18 | 4.18 | 5.39 | 11.02 | 0.3966 | 7.09 | 3.86 | 2,599,556.00 | 30.79 | -9.55 | 40.72 | -13.77 | 44.15 | 39.84 | 77.64 | -20.32 | 4.51 | -- | 0.07 | -- | -24.80 | 25.20 | -62.56 | -- | 15.93 | -- |
| Sunshine Lake Pharma Co Ltd | 3.82bn | -447.80m | 24.19bn | 6.53k | -- | 54.74 | 20,257.62 | 6.34 | -0.7765 | -0.7765 | 6.62 | 0.7672 | -- | -- | -- | 582,679.50 | -- | -- | -- | -- | 73.62 | -- | -12.86 | -- | 0.7739 | -0.7591 | 0.5111 | -- | -37.06 | -- | -212.17 | -- | -- | -- |
| The United Laboratories Intl. Hldgs Ltd. | 15.95bn | 3.46bn | 24.90bn | 17.40k | 6.62 | 1.30 | 5.98 | 1.56 | 1.91 | 1.91 | 8.78 | 9.69 | 0.5397 | 2.89 | 5.97 | 938,145.00 | 11.71 | 9.37 | 17.46 | 14.54 | 47.24 | 44.33 | 21.70 | 15.06 | 1.60 | -- | 0.2472 | 26.01 | 0.1387 | 10.39 | -1.54 | 32.89 | 37.25 | 45.96 |
| Shanghai Henlius Biotech Inc | 6.56bn | 932.24m | 24.90bn | 3.54k | 41.95 | 10.15 | 17.65 | 3.80 | 1.72 | 1.72 | 12.06 | 7.09 | 0.5386 | 1.73 | 5.86 | 1,865,468.00 | 7.66 | -3.21 | 13.85 | -5.76 | 75.77 | 72.50 | 14.22 | -7.87 | 0.5046 | 10.47 | 0.5185 | -- | 6.11 | 128.98 | 50.26 | -- | 10.83 | -- |
| PegBio Co Ltd | -100.00bn | -100.00bn | 26.11bn | 58.00 | -- | 89.25 | -- | -- | -- | -- | -- | 0.7479 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.07 | -- | 0.2439 | -- | -- | -- | -1.49 | -- | -- | -- |
| Grand Pharmaceutical Group Ltd | 11.70bn | 2.08bn | 26.83bn | 12.44k | 12.72 | 1.54 | 10.35 | 2.29 | 0.5943 | 0.5943 | 3.35 | 4.90 | 0.4557 | 3.66 | 3.88 | 976,472.80 | 7.99 | 10.40 | 10.81 | 14.24 | 57.64 | 61.04 | 17.53 | 22.80 | 0.9872 | -- | 0.2107 | 29.12 | 10.59 | 12.06 | 31.30 | 16.49 | 0.7398 | 22.05 |
| China Resources Pharmaceutical Group Ltd | 295.11bn | 3.19bn | 29.34bn | 86.00k | 9.19 | 0.5192 | 2.25 | 0.0994 | 0.5083 | 0.5083 | 46.97 | 8.99 | 0.9434 | 5.57 | 2.41 | 4,059,329.00 | 2.86 | 3.14 | 10.28 | 11.78 | 15.81 | 15.59 | 3.03 | 3.02 | 1.12 | 11.26 | 0.4248 | 22.38 | 5.30 | 7.41 | -13.06 | 2.95 | 12.42 | 7.30 |
| Duality Biotherapeutics Inc | 2.45bn | -3.20bn | 29.48bn | 191.00 | -- | 8.74 | -- | 12.01 | -36.93 | -36.93 | 28.67 | 37.42 | -- | -- | -- | 14,438,690.00 | -- | -- | -- | -- | 37.13 | -- | -130.43 | -- | -- | -- | 0.0228 | -- | 8.66 | -- | -193.82 | -- | -- | -- |
| Simcere Pharmaceutical Group Ltd | 8.04bn | 995.43m | 31.88bn | 6.82k | 30.35 | 3.71 | 22.87 | 3.97 | 0.4047 | 0.4047 | 3.26 | 3.31 | 0.5845 | 2.20 | 2.81 | 1,220,719.00 | 7.24 | 8.74 | 9.93 | 12.42 | 81.00 | 78.53 | 12.39 | 15.60 | 1.57 | 4.72 | 0.1453 | 44.12 | 0.4148 | 5.67 | 2.57 | -6.09 | 8.48 | -- |
| Xuanzhu Biopharmaceutical Co Ltd | 36.14m | -629.22m | 33.93bn | 197.00 | -- | 35.47 | -- | 938.68 | -1.21 | -1.21 | 0.0698 | 1.85 | -- | -- | -- | -- | -- | -- | -- | -- | 41.02 | -- | -1,740.97 | -- | 1.10 | -- | 0.0013 | -- | 103,672.40 | -- | -85.13 | -- | -- | -- |
| China Medical System Holdings Ltd | 8.89bn | 1.87bn | 36.57bn | 6.10k | 19.41 | 1.90 | 16.95 | 4.11 | 0.7721 | 0.7721 | 3.68 | 7.89 | 0.4239 | 3.14 | 6.12 | 1,447,511.00 | 8.85 | 16.35 | 9.88 | 18.70 | 71.47 | 75.03 | 20.88 | 32.20 | 5.28 | -- | 0.0417 | 40.16 | -6.79 | 4.22 | -32.54 | -3.75 | 6.01 | -2.60 |
Data as of Feb 13 2026. Currency figures normalised to China Medical System Holdings Ltd's reporting currency: Hong Kong Dollar HKD
15.64%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lazard Asset Management LLCas of 28 Jul 2025 | 121.07m | 4.96% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 55.66m | 2.28% |
| The Vanguard Group, Inc.as of 07 Jan 2026 | 47.48m | 1.95% |
| Foresight Fund Management Co., Ltd.as of 30 Jun 2025 | 29.56m | 1.21% |
| Dimensional Fund Advisors LPas of 08 Jan 2026 | 28.40m | 1.16% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 25.07m | 1.03% |
| Fidelity Management & Research Co. LLCas of 30 Nov 2025 | 24.96m | 1.02% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2025 | 17.12m | 0.70% |
| BlackRock Fund Advisorsas of 09 Jan 2026 | 16.72m | 0.69% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 15.55m | 0.64% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
